Preferred Label : MAP Kinase Activation Pathway;
NCIt related terms : Role of beta-arrestins in the activation and targeting of MAP kinases;
Alternative definition : BIOCARTA: The binding of b-arrestins to agonist-occupied GPCRs triggers the assembly
of a MAP kinase activation complex using b-arrestin as a scaffold, with subsequent
activation of a b-arrestin-bound pool of ERK1/2. The receptor-b-arrestin-ERK complexes
are localized to endosomal vesicles, and their formation does not result in nuclear
translocation of activated ERK1/2 or stimulation of cell proliferation. The function
of b-arrestin-bound ERK1/2 is presently unknown. Activation of ERK1/2 by b-arrestin
scaffolds may favor the phosphorylation of plasma membrane, cytosolic, or cytoskeletal
ERK1/2 substrates, or it may lead to transcriptional activation through the ERK-dependent
activation of other kinases. The model depicts b-arrestin scaffolding of the ERK1/2
MAP kinase cascade, based upon data obtained with the protease-activated PAR2 and
angiotensin AT1a receptors. A similar mechanism has been proposed for regulation of
the JNK3 MAP kinase cascade by AT1a receptors. (This definition may be outdated -
see the DesignNote.);
NCIt note : The BIOCARTA Definition (ALT_DEFINITION) for this pathway concept was provided by
BioCarta. This property was not created by, nor is it maintained by the NCI Thesaurus
staff. Additionally, BioCarta is no longer updating its pathway data; thus, the BIOCARTA
Definition might be outdated or inaccurate. Please see the Terms and Conditions for
Use at http://www.biocarta.com/.;
Biocarta ID : h_barr-mapkPathway;
Origin ID : C39002;
UMLS CUI : C1518104;
Semantic type(s)
has_gene_product_element
pathway_has_gene_element